Soluble Vascular Endothelial Growth Factor Receptor-2 and Inflammatory Factors in Macular Edema with Branch Retinal Vein Occlusion

被引:43
|
作者
Noma, Hidetaka [1 ]
Funatsu, Hideharu [1 ]
Mimura, Tatsuya [2 ]
Eguchi, Shuichiro [3 ]
Hori, Sadao [4 ]
机构
[1] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Ophthalmol, Chiba 2768524, Japan
[2] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan
[3] Eguchi Eye Hosp, Dept Ophthalmol, Hakodate, Hokkaido, Japan
[4] Tokyo Womens Med Univ, Dept Ophthalmol, Tokyo, Japan
关键词
NF-KAPPA-B; INTRAVITREAL BEVACIZUMAB; VITREOUS LEVELS; LASER TREATMENT; ACTIVATION; EXPRESSION; INHIBITOR; CYTOKINES; VEGFR-2; PHOSPHORYLATION;
D O I
10.1016/j.ajo.2011.04.006
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To investigate relationships among vitreous fluid levels of soluble vascular endothelial growth factor receptor-2 (sVEGFR-2), vascular endothelial growth factor (VEGF), and soluble intercellular adhesion molecule 1 (sICAM-1) in patients with branch retinal vein occlusion (BRVO) and macular edema or patients with idiopathic macular hole. DESIGN: Retrospective case-control study. METHODS: SETTING: Tokyo Women's Medical University and Eguchi Eye Hospital. PATIENT POPULATION: Forty-nine Japanese patients who underwent unilateral vitrectomy (27 with BRVO and 22 with macular hole). OBSERVATION PROCEDURES: Vitreous fluid samples were obtained during vitreoretinal surgery to measure the levels of sVEGFR-2, VEGF, and sICAM-1. Retinal ischemia was evaluated from capillary nonperfusion on fluorescein angiography. Macular edema was examined by optical coherence tomography. MAIN OUTCOME MEASURES: Vitreous fluid levels of the 3 molecules and severity of macular edema. RESULTS: BRVO patients had a significantly higher vitreous fluid level of sVEGFR-2 (median, 1670 pg/mL; interquartile range [IQL], 1205 to 2225 pg/mL) than macular hole patients (median, 1265 pg/mL; IQR, 731 to 1800 pg/mL; P = .017), as was the case for VEGF (median, 237 pg/mL; IQR, 42.2 to 1305 pg/mL; vs median, 15.6 pg/mL; IQR, 15.6 to 15.6 pg/mL; P < .001) and sICAM-1 (median, 10.1 ng/mL; IQR, 6.3 to 22.5 ng/mL; vs median, 4.1 ng/mL; IQR, 3.3 to 6.0 ng/mL; P < .001). In BRVO patients, there was a significant positive correlation between vitreous fluid levels of sVEGFR-2 or VEGF and sICAM-1, but not between sVEGFR-2 and VEGF. Vitreous fluid levels of all 3 molecules were correlated significantly the with severity of macular edema in BRVO patients. CONCLUSIONS: sVEGFR-2 may induce an increase of vascular permeability together with or via sICAM-1, or both with and via sICAM-1, in BRVO patients with macular edema. (Am J Ophthalmol 2011;152:669-677. (C) 2011 by Elsevier Inc. All rights reserved.)
引用
收藏
页码:669 / 677
页数:9
相关论文
共 50 条
  • [31] Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study
    Hidetaka Noma
    Hideharu Funatsu
    Tatsuya Mimura
    Katsunori Shimada
    Journal of Inflammation, 7
  • [32] Vitreous inflammatory factors in macular edema with central retinal vein occlusion
    Hidetaka Noma
    Hideharu Funatsu
    Seiyo Harino
    Tatsuya Mimura
    Shuichiro Eguchi
    Sadao Hori
    Japanese Journal of Ophthalmology, 2011, 55 : 248 - 255
  • [33] Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study
    Noma, Hidetaka
    Funatsu, Hideharu
    Mimura, Tatsuya
    Shimada, Katsunori
    JOURNAL OF INFLAMMATION-LONDON, 2010, 7
  • [34] Vitreous inflammatory factors in macular edema with central retinal vein occlusion
    Noma, Hidetaka
    Funatsu, Hideharu
    Harino, Seiyo
    Mimura, Tatsuya
    Eguchi, Shuichiro
    Hori, Sadao
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2011, 55 (03) : 248 - 255
  • [35] Characteristics of Patients Who Drop Out of Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Associated with Branch Retinal Vein Occlusion
    Kawakami, Setsuko
    Wakabayashi, Yoshihiro
    Watanabe, Yoko
    Umazume, Kazuhiko
    Yamamoto, Kaori
    Goto, Hiroshi
    JOURNAL OF OPHTHALMOLOGY, 2024, 2024
  • [36] Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
    Mashima, Asako
    Noma, Hidetaka
    Yasuda, Kanako
    Goto, Hiroshi
    Shimura, Masahiko
    JOURNAL OF INFLAMMATION-LONDON, 2019, 16 (1):
  • [37] Anti-vascular endothelial growth factor agents reduce inflammation in central retinal vein occlusion with macular edema
    Noma, Hidetaka
    Yasuda, Kanako
    Shimura, Masahiko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [38] Vitreous Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Macular Edema with Central Retinal Vein Occlusion
    Noma, Hidetaka
    Funatsu, Hideharu
    Mimura, Tatsuya
    Harino, Seiyo
    Hori, Sadao
    OPHTHALMOLOGY, 2009, 116 (01) : 87 - 93
  • [39] Effect of Vascular Endothelial Growth Factor on Vision Improvement in Patients With Macular Edema Due to Central Retinal Vein Occlusion
    Kawamura, H.
    Sawada, O.
    Kakinoki, M.
    Sawada, T.
    Ohji, M. M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [40] Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
    Asako Mashima
    Hidetaka Noma
    Kanako Yasuda
    Hiroshi Goto
    Masahiko Shimura
    Journal of Inflammation, 16